144.62USD+0.15%Mkt Cap: 21.88B USDP/E: 26.30Last update: 2026-05-26
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and arr…
Industry Peers
Diagnostics & ResearchIndicators:|
Key Statistics
Company
Market Cap21.88B USD
Enterprise Value23.30B USD
Revenue (TTM)4.39B USD
Gross Profit2.87B USD
Net Income (TTM)850.00M USD
Revenue/Share28.62 USD
Last Price144.62 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees8.6K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)26.30
P/E (Forward)24.42
PEG2.49
EV/EBITDA20.18
EV/Revenue5.30
P/S4.99
P/B8.23
EPS (TTM)5.50
EPS (Forward)5.93
52W Range
78.5586% of range155.53
52W High155.53 USD
52W Low78.55 USD
Profitability
Gross Margin66.08%
Oper. Margin18.33%
EBITDA Margin26.29%
Profit Margin19.57%
ROE31.22%
ROA12.79%
Growth
Revenue Growth4.80%
Earnings Growth6.10%
Cash Flow & Leverage
Operating CF1.08B USD
CapEx (TTM)148.00M USD
FCF Margin19.25%
FCF Yield3.86%
Net Debt1.39B USD
Net Debt/EBITDA1.20
Balance Sheet
Debt/Equity0.94
Current Ratio1.75
Quick Ratio1.23
Book Value/Sh17.61 USD
Cash/Share7.634 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1028:1000
Split DateJun 25, 2024
Analyst Consensus
Rating2.3 (Buy)
Target (Mean)143.63 USD
Target Range95.00 USD – 175.00 USD
# Analysts19
Ownership
Shares Out.151.30M
Float147.38M
Insiders0.21%
Institutions106.68%
Short Interest
Short Ratio4.7d
Short % Float7.07%
Short % Out.4.33%
Shares Short6.55M
Short (prev mo.)6.96M
Technical
SMA 50130.51 (+10.8%)
SMA 200120.84 (+19.7%)
Beta1.42
S&P 52W Chg28.31%
Avg Vol (30d)1.56M
Avg Vol (10d)1.81M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—